Fundz

Immunomic Therapeutics, Inc. reported raising $315,000 in an initial SEC Form D filing, from an offering of $315,000

PRIVATEAug 03, 2018

Amount Raised

$315,000

$315,000 sold, per SEC Form D (first sale Aug 3, 2018)

Round Type

Venture

RockvilleBiotechnology

Quick answer

Immunomic Therapeutics, Inc. raised $315,000 in a funding round, dated August 3, 2018. Immunomic Therapeutics, Inc. is based in Rockville, Maryland, United States.

How much did Immunomic Therapeutics, Inc. raise?
Immunomic Therapeutics, Inc. raised $315,000 in a funding round on August 3, 2018.
What does Immunomic Therapeutics, Inc. do?
The privately-held biotechnology company is pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors.
Where is Immunomic Therapeutics, Inc. based and how big is it?
Immunomic Therapeutics, Inc. is based in Rockville, Maryland, United States. Fundz records about 24 employees.
Who are the decision-makers at Immunomic Therapeutics, Inc?
Fundz holds 2 contacts at Immunomic Therapeutics, Inc. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Immunomic Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Inscripta raised $1.1M (Seed) on September 17, 2018.
  • Euphrates Vascular, Inc. raised $590K (Seed) on September 17, 2018.
  • Propanc Biopharma raised $158K (Pre-Seed) on September 17, 2018.
  • MARIZYME INC raised $15M on September 17, 2018.
  • BiOWiSH Technologies raised $7.5M on September 14, 2018.
  • Artelo Biosciences raised $526K on September 14, 2018.

Who to call at Immunomic Therapeutics, Inc., and when

A new round usually means Immunomic Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Immunomic Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Immunomic Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Immunomic Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Immunomic Therapeutics, Inc.

Location

ATTN: C. Eric Winze, 15010 BROSCHART RD.

Rockville, Maryland, United States

About

The privately-held biotechnology company is pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies for the treatment of refractory cancers and solid tumors. It has established proof of concept data demonstrating the therapeutic potential for the treatment of multiple solid tumors, including colorectal, pancreatic, mesothelioma, ovarian and breast cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Immunomic Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts12 people are listed at Immunomic Therapeutics, I…. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Immunomic Therapeutics, Inc.'s next move

See what Strategic adds

Immunomic Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.